Megan L'Heureux

Experts weigh in on the biggest challenges in cultivating cannabis.

David L. Nathan, MD, DFAPA, President, Board of Directors, Doctors for Cannabis Regulations (DFCR), discusses how the DFCR was formed, the efforts they have been making in the cannabis field, and plans for the future of the organization.

David L. Nathan, MD, DFAPA, President, Board of Directors, Doctors for Cannabis Regulations (DFCR), discusses how the DFCR was formed, the efforts they have been making in the cannabis field, and plans for the future of the organization.

John A. MacKay, Synergistic Technologies Associates and Brian C. Smith, Big Sur Scientific discuss the biggest challenges in cannabis related to extraction.

Ken Villazor, President and CEO of Flower One Holdings, recently spoke to us about the large-scale cultivation and production facility they’ve begun operating in Las Vegas.

Arcadia Biosciences, Inc. (Davis, California), an agricultural food ingredient company that is known for leveraging advanced, proprietary breeding techniques to improve the quality and nutritional content of wheat and soybeans, announced that they will apply their expertise cannabis.

A letter from editor-in-chief, Megan L'Heureux, announcing new columns and plans for Cannabis Science and Technology in 2019. 

Here we take a closer look at Australia’s medical cannabis program, the laws surrounding it, and speak to Australian pharmacist Paul Mavor.

Here we take a closer look at Australia’s medical cannabis program, the laws surrounding it, and speak to Australian pharmacist Paul Mavor.

Dr. Ethan Russo, Director of Research and Development for the International Cannabis and Cannabinoids Institute (ICCI), recently spoke with us about some of his recent research efforts, cannabis dosing, and his continued push to change the stigma against cannabis as a medicine.

Paul Mavor, an Australian and UK licensed pharmacist and the CEO and Founder of Health House International, recently spoke to us about Australia’s medical cannabis program, the testing and regulations in place, and the future outlook for cannabis in his country.

Paul Mavor, an Australian and UK licensed pharmacist and the CEO and Founder of Health House International, recently spoke to us about Australia’s medical cannabis program, the testing and regulations in place, and the future outlook for cannabis in his country.

President Trump’s nominee for Attorney General, William Barr, stated in his confirmation hearing that he would not go after cannabis companies that were compliant with state laws. In a recent letter in response to written questions from various senators, Barr has put that statement in writing.

We took a look at our most read articles from 2018; here are the top 8. 

Dr. Markus Roggen discusses his experiences in the industry and what extraction methods he has used.

The next step in the lawsuit against the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) was heard this week at the United States Court of Appeals for the Second Circuit.

The New Zealand government passed a law on December 11, 2018, that will establish a regulated medical cannabis scheme within one year.

Josh Blacher, Chief Business Officer at InMed Pharmaceuticals, recently spoke to us about the groundbreaking researching his company is doing using biosynthesis to create cannabinoid-based pharmaceutical products.

Jeff Zorn, the CEO and Owner of Cannabis Training University, discusses the different courses they offer, what sets them apart from other cannabis training facilities, and more.

We recently spoke with Eric Furman, PhD, a partner at Knobbe Martens a leading intellectual property law firm with an expansive presence in the biotech and pharmaceutical fields and deep experience in intellectual property issues relating to the cannabis industry. Here, Furman provides some insight on what cases are currently on-going and what we might expect in the future as the cannabis industry continues to expand.

Dr. Les Brown, Managing Director of AECS-QuikPrep Ltd., recently spoke to us about the benefits of countercurrent chromatography (CCC) compared to other methods as well as the work his company has been doing to advance the technique for their clients in the cannabis industry.

Cannabis Science and Technology is pleased to announce the launch of its editorial advisory board. 

The University of Connecticut (UConn, Storrs, Connecticut) announced plans to offer a class on cannabis horticulture through the Department of Plant Science and Landscape Architecture.